Katharina A Ponto1,2, Jochem Koenig3, Tunde Peto4, Julia Lamparter5, Philipp Raum5, Philipp S Wild6,7,8, Karl J Lackner9, Norbert Pfeiffer5, Alireza Mirshahi5,10. 1. Department of Ophthalmology, University Medical Center Mainz, Langenbeckstrasse 1, 55131, Mainz, Germany. katharina.ponto@unimedizin-mainz.de. 2. Center for Thrombosis and Hemostasis, University Medical Center, Mainz, Germany. katharina.ponto@unimedizin-mainz.de. 3. Institute of Medical Biostatistics, Epidemiology and Informatics, Division of Biostatistics and Bioinformatics, University Medical Center, Mainz, Germany. 4. NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK. 5. Department of Ophthalmology, University Medical Center Mainz, Langenbeckstrasse 1, 55131, Mainz, Germany. 6. Center for Thrombosis and Hemostasis, University Medical Center, Mainz, Germany. 7. Preventive Cardiology and Preventive Medicine, Department of Medicine II, University Medical Center, Mainz, Germany. 8. DZHK (German Center for Cardiovascular Research), Partner Site Rhine Main, Mainz, Germany. 9. Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center, Mainz, Germany. 10. Dardenne Eye Hospital, Bonn-Bad Godesberg, Germany.
Abstract
AIMS/HYPOTHESIS: Individuals with type 2 diabetes mellitus may experience an asymptomatic period of hyperglycaemia, and complications may already be present at the time of diagnosis. We aimed to determine the prevalence of diabetic retinopathy in patients with newly diagnosed (screening-detected) type 2 diabetes. METHODS: The Gutenberg Health Study is a population-based study with 15,010 participants aged between 35 and 74 years. We determined the weighted prevalence of diabetic retinopathy by assessing fundus photographs. Screening-detected type 2 diabetes was defined as an HbA1c concentration of 6.5% (47.5 mmol/mol) or more, no medical diagnosis of diabetes and no intake of insulin or oral glucose-lowering agents. RESULTS: Of 14,948 participants, 1377 (9.2%) had diabetes mellitus. Of these, 347 (25.2%) had newly diagnosed type 2 diabetes detected by the screening. Overall, the weighted prevalence of screening-detected type 2 diabetes was 2.1%. Fundus photos were evaluable for 285 (82.1%) participants with newly diagnosed diabetes. The weighted prevalence of diabetic retinopathy in screening-detected type 2 diabetes was 13.0%; 12% of participants had a mild non-proliferative diabetic retinopathy and 0.6% had a moderate non-proliferative diabetic retinopathy. Diabetic retinopathy was proliferative in 0.3%. No cases of severe non-proliferative diabetic retinopathy or diabetic maculopathy were found. Thirty (14.9%) of 202 and six (7.2%) of 83 individuals with and without concomitant arterial hypertension, respectively, had diabetic retinopathy (OR 2.54, 95% CI 1.06, 7.14). Visual acuity did not differ between individuals with and without diabetic retinopathy . CONCLUSIONS/ INTERPRETATION: In this large European study, the prevalence of diabetic retinopathy in screening-detected type 2 diabetes was 13%. Only a very small proportion of participants with detected diabetic retinopathy needed treatment.
AIMS/HYPOTHESIS: Individuals with type 2 diabetes mellitus may experience an asymptomatic period of hyperglycaemia, and complications may already be present at the time of diagnosis. We aimed to determine the prevalence of diabetic retinopathy in patients with newly diagnosed (screening-detected) type 2 diabetes. METHODS: The Gutenberg Health Study is a population-based study with 15,010 participants aged between 35 and 74 years. We determined the weighted prevalence of diabetic retinopathy by assessing fundus photographs. Screening-detected type 2 diabetes was defined as an HbA1c concentration of 6.5% (47.5 mmol/mol) or more, no medical diagnosis of diabetes and no intake of insulin or oral glucose-lowering agents. RESULTS: Of 14,948 participants, 1377 (9.2%) had diabetes mellitus. Of these, 347 (25.2%) had newly diagnosed type 2 diabetes detected by the screening. Overall, the weighted prevalence of screening-detected type 2 diabetes was 2.1%. Fundus photos were evaluable for 285 (82.1%) participants with newly diagnosed diabetes. The weighted prevalence of diabetic retinopathy in screening-detected type 2 diabetes was 13.0%; 12% of participants had a mild non-proliferative diabetic retinopathy and 0.6% had a moderate non-proliferative diabetic retinopathy. Diabetic retinopathy was proliferative in 0.3%. No cases of severe non-proliferative diabetic retinopathy or diabetic maculopathy were found. Thirty (14.9%) of 202 and six (7.2%) of 83 individuals with and without concomitant arterial hypertension, respectively, had diabetic retinopathy (OR 2.54, 95% CI 1.06, 7.14). Visual acuity did not differ between individuals with and without diabetic retinopathy . CONCLUSIONS/ INTERPRETATION: In this large European study, the prevalence of diabetic retinopathy in screening-detected type 2 diabetes was 13%. Only a very small proportion of participants with detected diabetic retinopathy needed treatment.
Authors: Amber A W A van der Heijden; Iris Walraven; Esther van 't Riet; Thor Aspelund; Sigrún H Lund; Petra Elders; Bettine C P Polak; Annette C Moll; Jan E E Keunen; Jacqueline M Dekker; Giel Nijpels Journal: Diabetologia Date: 2014-04-26 Impact factor: 10.122
Authors: A M W Spijkerman; J M Dekker; G Nijpels; A Jager; P J Kostense; V W M van Hinsbergh; L M Bouter; R J Heine; C D A Stehouwer Journal: Eur J Clin Invest Date: 2002-12 Impact factor: 4.686
Authors: M C Adriaanse; F J Snoek; J M Dekker; A M W Spijkerman; G Nijpels; J W R Twisk; H M van der Ploeg; R J Heine Journal: Diabet Med Date: 2004-09 Impact factor: 4.359
Authors: M Cignarelli; M L De Cicco; A Damato; A Paternostro; S Pagliarini; S Santoro; L Cardia; G De Pergola; R Giorgino Journal: Diabetes Care Date: 1992-08 Impact factor: 19.112
Authors: Kristina J H Kleinwort; Barbara Amann; Stefanie M Hauck; Sieglinde Hirmer; Andreas Blutke; Simone Renner; Patrizia B Uhl; Karina Lutterberg; Walter Sekundo; Eckhard Wolf; Cornelia A Deeg Journal: Diabetologia Date: 2017-05-08 Impact factor: 10.122